… and safety of once-weekly semaglutide 1.0 mg vs once-daily liraglutide 1.2 mg as add-on to 1–3 oral antidiabetic drugs in subjects with type 2 diabetes (SUSTAIN 10)
1. 请及时下载文件确认是否正确, 系统将在 2026-07-03 10:13:18 删除文件
2. 如若文件有误请驳回应助文件, 求助状态即回到求助中
3. 如若文件正确请及时点击确认, 若超过时后系统自动默认为已完结
注: 所有应助的资源仅供学习交流使用, 不得违反相关法律法规
DOI:
文献链接:
其他信息:
MS Capehorn, AM Catarig, JK Furberg, A Janez…
Diabetes & …, 2020
Elsevier
Aims SUSTAIN 10 compared the efficacy and safety of the anticipated most frequent semaglutide
dose (1.0 mg) with the current most frequently prescribed liraglutide dose in Europe (…

